Skip to main content

Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc is an American commercial-stage biopharmaceutical enterprise headquartered in Washington, DC. The company specializes in the research, development, and commercialization of innovative specialty pharmaceutical products targeting central nervous system disorders and rare diseases, including treatments for sleep-wake disorders and psychiatric conditions. Principal revenue is derived through commercial pharmaceutical product sales of approved prescription medications (such as Hetlioz and Fanapt) to healthcare markets. Vanda Pharmaceuticals is publicly listed on the Nasdaq Stock Market.

3 of the funds FundTelligence covers report a position in Vanda Pharmaceuticals.

Legal name
VANDA PHARMACEUTICALS INC
Sector
Health Care
Country
United States
Funds holding it
3
Exposure themes
Mental Health, Psychiatry, Schizophrenia & Psychosis

Funds holding Vanda Pharmaceuticals

Loading...